Mercer Global Advisors’s Medifast MED Stock Holding History

Mercer Global Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$178K	Buy	16,782 +6,566	+64%	+$75.7K	﹤0.01%	3293
2026 Q1	$104K	Buy	+10,216	New	+$110K	﹤0.01%	3009
2025 Q4	–	Sell	-10,535	Closed	-$144K	–	2930
2025 Q3	$144K	Buy	+10,535	New	+$147K	﹤0.01%	2460
2023 Q4	–	Sell	-7,164	Closed	-$536K	–	2061
2023 Q3	$536K	Sell	7,164 -944	-12%	-$83.7K	﹤0.01%	1217
2023 Q2	$747K	Buy	+8,108	New	+$722K	﹤0.01%	1060

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mercer Global Advisors's MED Position: Q2 2026 in Review

Mercer Global Advisors increased its Medifast (MED) stake by 64% in Q2 2026, buying an estimated $75.7K and bringing the position to 16,782 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #3293.

Mercer Global Advisors first reported a position in MED in Q2 2023 and has held it in 5 quarters since. The position peaked at $747K in Q2 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Mercer Global Advisors held 16,782 shares of Medifast worth $178K as of Q2 2026.
Mercer Global Advisors bought 6,566 Medifast shares in Q2 2026, an estimated $75.7K.
Medifast made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3293 holding.
Mercer Global Advisors first reported a position in Medifast in Q2 2023 and has held it in 5 quarters since.
Mercer Global Advisors's Medifast position peaked at $747K in Q2 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.